Hyloris Pharmaceuticals SA (HYL.BR)

EUR 6.35

(0.05%)

Total Assets Summary of Hyloris Pharmaceuticals SA

Hyloris Pharmaceuticals SA's latest annual total assets in 2023 was 47.68 Million EUR , down -22.93% from previous year.
Hyloris Pharmaceuticals SA's latest quarterly total assets in 2023 FY was 47.68 Million EUR , down -22.93% from previous quarter.
Hyloris Pharmaceuticals SA reported annual total assets of 61.86 Million EUR in 2022, down -2.49% from previous year.
Hyloris Pharmaceuticals SA reported annual total assets of 63.44 Million EUR in 2021, down -8.29% from previous year.
Hyloris Pharmaceuticals SA reported quarterly total assets of 47.68 Million EUR for 2023 Q3, down -16.75% from previous quarter.
Hyloris Pharmaceuticals SA reported quarterly total assets of 57.27 Million EUR for 2023 Q1, down -7.42% from previous quarter.

Annual Total Assets Chart of Hyloris Pharmaceuticals SA (2023 - 2016)

Historical Annual Total Assets of Hyloris Pharmaceuticals SA (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	47.68 Million EUR	-22.93%
2022	61.86 Million EUR	-2.49%
2021	63.44 Million EUR	-8.29%
2020	69.18 Million EUR	1056.31%
2019	5.98 Million EUR	-24.72%
2018	7.94 Million EUR	82.08%
2017	4.36 Million EUR	224.54%
2016	1.34 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2023 Q2	57.27 Million EUR	0.0%
2023 Q3	47.68 Million EUR	-16.75%
2023 Q1	57.27 Million EUR	-7.42%
2023 FY	47.68 Million EUR	-22.93%
2023 Q4	47.68 Million EUR	0.0%
2022 Q1	72.96 Million EUR	15.01%
2022 Q2	72.96 Million EUR	0.0%
2022 Q3	60.72 Million EUR	-16.77%
2022 FY	61.86 Million EUR	-2.49%
2022 Q4	61.86 Million EUR	1.87%
2021 Q1	63.98 Million EUR	-7.51%
2021 FY	63.44 Million EUR	-8.29%
2021 Q4	63.44 Million EUR	0.0%
2021 Q3	63.44 Million EUR	-0.84%
2021 Q2	63.98 Million EUR	0.0%
2020 Q4	69.18 Million EUR	0.0%
2020 Q3	69.18 Million EUR	-3.66%
2020 Q1	20.49 Million EUR	242.52%
2020 FY	69.18 Million EUR	1056.31%
2020 Q2	71.81 Million EUR	250.43%
2019 Q3	5.98 Million EUR	0.0%
2019 Q4	5.98 Million EUR	0.0%
2019 FY	5.98 Million EUR	-24.72%
2019 Q1	- EUR	0.0%
2018 FY	7.94 Million EUR	82.08%
2017 FY	4.36 Million EUR	224.54%
2016 FY	1.34 Million EUR	0.0%

Peer Total Assets Comparison of Hyloris Pharmaceuticals SA

Name	Total Assets	Total Assets Difference
Nicox S.A.	52.98 Million EUR	10.002%
European Medical Solutions	43.75 Million EUR	-8.965%
FERMENTALG	50.24 Million EUR	5.101%
argenx SE	4.11 Billion EUR	98.84%
BioSenic S.A.	9.55 Million EUR	-398.807%
Celyad Oncology SA	16.28 Million EUR	-192.845%
Onward Medical N.V.	43.62 Million EUR	-9.287%
Oxurion NV	6.55 Million EUR	-627.954%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	7.067%
Financière de Tubize SA	1.92 Billion EUR	97.517%
UCB SA	15.53 Billion EUR	99.693%